Venmax Drugs & Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 1.21 | 1.36 | 0.20 |
| Operating Expense | 1.17 | 0.58 | 0.69 |
| Net Profit | 0.04 | 0.78 | -0.50 |
| Net Profit Margin | 3.31 | 57.35 | -250 |
| Earning Per Share | 0.07 | 1.49 | -0.95 |
| EBIDTA | 0.04 | 0.78 | -0.50 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 1.21 |
| Operating Expense | 1.17 |
| Net Profit | 0.04 |
| Net Profit Margin | 3.31 |
| Earning Per Share | 0.07 |
| EBIDTA | 0.04 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 0.81 | TBA | TBA |
| Operating Expenses Annual | 1.87 | 0.10 | 0.19 |
| Operating Profit Annual | -0.01 | 0.09 | 0.23 |
| Interest Annual | 0.00 | TBA | TBA |
| Depreciation | TBA | TBA | TBA |
| Net Profit Annual | -0.01 | 0.06 | 0.23 |
| Tax Annual | -0.00 | 0.02 | 0.00 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 0.81 |
| Operating Expenses Annual | 1.87 |
| Operating Profit Annual | -0.01 |
| Interest Annual | 0.00 |
| Depreciation | TBA |
| Net Profit Annual | -0.01 |
| Tax Annual | -0.00 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | TBA | TBA | TBA |
| Cash Flow from Operations | -2.29 | TBA | TBA |
| Cash Flow from Investing | TBA | TBA | TBA |
| Cash Flow from Financing | 4.77 | TBA | TBA |
| Cash Flow at the End | 2.48 | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | TBA |
| Cash Flow from Operations | -2.29 |
| Cash Flow from Investing | TBA |
| Cash Flow from Financing | 4.77 |
| Cash Flow at the End | 2.48 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 14.81 | TBA | TBA |
| PBIT Margin (%) | 13.58 | TBA | TBA |
| PBT Margin (%) | 13.58 | TBA | TBA |
| Net PROFIT Margin (%) | -1.23 | TBA | TBA |
| Return On Networth / Equity (%) | TBA | 1.15 | 4.10 |
| Return On Networth /Employed (%) | TBA | 1.43 | 3.86 |
| Return On Assets (%) | -0.48 | TBA | TBA |
| Total Debt / Equity (X) | 0.11 | TBA | TBA |
| Asset Turnover Ratio (%) | 0.39 | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 14.81 |
| PBIT Margin (%) | 13.58 |
| PBT Margin (%) | 13.58 |
| Net PROFIT Margin (%) | -1.23 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -0.48 |
| Total Debt / Equity (X) | 0.11 |
| Asset Turnover Ratio (%) | 0.39 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 0.04 | 0.07 | 0.07 |
| Total Current Assets Annual | 5.13 | 0.02 | 0.14 |
| Non Current Assets Annual | 0.04 | 0.07 | 0.07 |
| Total Shareholders Funds Annual | 4.41 | -0.65 | -0.71 |
| Total Assets Annual | 5.17 | 0.08 | 0.21 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 0.04 |
| Total Current Assets Annual | 5.13 |
| Non Current Assets Annual | 0.04 |
| Total Shareholders Funds Annual | 4.41 |
| Total Assets Annual | 5.17 |
No Data Availabe
